BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
1.620
-0.080 (-4.71%)
Jul 26, 2024, 4:00 PM EDT - Market closed
BioAtla Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 0.25 | 0.43 | 5.2 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | -41.72% | -91.75% | -51.07% | Upgrade
|
| Cost of Revenue | 100.89 | 103.73 | 79.35 | 58.27 | 19.93 | 25.92 | Upgrade
|
| Gross Profit | -100.89 | -103.73 | -79.35 | -58.02 | -19.5 | -20.72 | Upgrade
|
| Selling, General & Admin | 24.33 | 25.96 | 28.79 | 38.42 | 10.6 | 7.55 | Upgrade
|
| Operating Expenses | 24.33 | 25.96 | 28.79 | 38.42 | 10.6 | 7.55 | Upgrade
|
| Operating Income | -125.21 | -129.69 | -108.14 | -96.44 | -30.1 | -28.27 | Upgrade
|
| Interest Expense | - | - | - | -0 | -1.39 | -1.63 | Upgrade
|
| Interest & Investment Income | 6.06 | 6.31 | 1.65 | 0.35 | 0.1 | 0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | -0.09 | 0.01 | 0 | -1.58 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -119.24 | -123.46 | -106.48 | -96.09 | -32.97 | -29.86 | Upgrade
|
| Other Unusual Items | - | - | - | 0.69 | -2.88 | - | Upgrade
|
| Pretax Income | -119.24 | -123.46 | -106.48 | -95.4 | -35.85 | -29.86 | Upgrade
|
| Earnings From Continuing Operations | -119.24 | -123.46 | -106.48 | -95.4 | -35.85 | -29.86 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | 0.06 | Upgrade
|
| Net Income | -119.24 | -123.46 | -106.48 | -95.4 | -35.85 | -29.79 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | -8.98 | -1.06 | Upgrade
|
| Net Income to Common | -119.24 | -123.46 | -106.48 | -95.4 | -26.88 | -28.73 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 48 | 39 | 35 | 8 | 55 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 48 | 39 | 35 | 8 | 55 | Upgrade
|
| Shares Change (YoY) | 15.46% | 22.74% | 12.63% | 310.07% | -84.56% | 1200.00% | Upgrade
|
| EPS (Basic) | -2.49 | -2.58 | -2.74 | -2.76 | -3.19 | -0.53 | Upgrade
|
| EPS (Diluted) | -2.49 | -2.58 | -2.74 | -2.76 | -3.19 | -0.53 | Upgrade
|
| Free Cash Flow | -112.24 | -104.11 | -90.69 | -63.14 | -36.92 | -11.15 | Upgrade
|
| Free Cash Flow Per Share | -2.34 | -2.18 | -2.33 | -1.83 | -4.38 | -0.20 | Upgrade
|
| Operating Margin | - | - | - | -38576.00% | -7016.08% | -543.62% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -25255.20% | -8606.99% | -214.50% | Upgrade
|
| EBITDA | -124.05 | -128.47 | -106.94 | -95.11 | -29.09 | -27.41 | Upgrade
|
| D&A For EBITDA | 1.17 | 1.22 | 1.2 | 1.33 | 1.01 | 0.86 | Upgrade
|
| EBIT | -125.21 | -129.69 | -108.14 | -96.44 | -30.1 | -28.27 | Upgrade
|
Source: S&P Capital IQ. Standard template.